UniProt ID | CO2_HUMAN | |
---|---|---|
UniProt AC | P06681 | |
Protein Name | Complement C2 | |
Gene Name | C2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 752 | |
Subcellular Localization | Secreted. | |
Protein Description | Component C2 which is part of the classical pathway of the complement system is cleaved by activated factor C1 into two fragments: C2b and C2a. C2a, a serine protease, then combines with complement factor C4b to generate the C3 or C5 convertase.. | |
Protein Sequence | MGPLMVLFCLLFLYPGLADSAPSCPQNVNISGGTFTLSHGWAPGSLLTYSCPQGLYPSPASRLCKSSGQWQTPGATRSLSKAVCKPVRCPAPVSFENGIYTPRLGSYPVGGNVSFECEDGFILRGSPVRQCRPNGMWDGETAVCDNGAGHCPNPGISLGAVRTGFRFGHGDKVRYRCSSNLVLTGSSERECQGNGVWSGTEPICRQPYSYDFPEDVAPALGTSFSHMLGATNPTQKTKESLGRKIQIQRSGHLNLYLLLDCSQSVSENDFLIFKESASLMVDRIFSFEINVSVAIITFASEPKVLMSVLNDNSRDMTEVISSLENANYKDHENGTGTNTYAALNSVYLMMNNQMRLLGMETMAWQEIRHAIILLTDGKSNMGGSPKTAVDHIREILNINQKRNDYLDIYAIGVGKLDVDWRELNELGSKKDGERHAFILQDTKALHQVFEHMLDVSKLTDTICGVGNMSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGLYNPCLGSADKNSRKRAPRSKVPPPRDFHINLFRMQPWLRQHLGDVLNFLPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 (in isoform 2) | Phosphorylation | - | 10.69 | 24719451 | |
29 | N-linked_Glycosylation | PSCPQNVNISGGTFT CCCCCCEEECCCEEE | 30.20 | UniProtKB CARBOHYD | |
72 | O-linked_Glycosylation | KSSGQWQTPGATRSL CCCCCCCCCCCCCCC | 22.26 | OGP | |
111 (in isoform 2) | Phosphorylation | - | 31.44 | - | |
112 | N-linked_Glycosylation | GSYPVGGNVSFECED CCCCCCCCEEEEECC | 21.96 | 16335952 | |
126 | Phosphorylation | DGFILRGSPVRQCRP CCEEECCCCCCCCCC | 17.49 | 26329039 | |
178 | Phosphorylation | DKVRYRCSSNLVLTG CCEEEEECCCEEEEC | 17.17 | - | |
179 | Phosphorylation | KVRYRCSSNLVLTGS CEEEEECCCEEEECC | 37.50 | - | |
186 | Phosphorylation | SNLVLTGSSERECQG CCEEEECCCCEECCC | 24.64 | - | |
208 | Phosphorylation | EPICRQPYSYDFPED CCCCCCCCCCCCCCC | 16.12 | 24275569 | |
222 | Phosphorylation | DVAPALGTSFSHMLG CHHHHHCCHHHHHHC | 27.70 | 24275569 | |
225 | Phosphorylation | PALGTSFSHMLGATN HHHCCHHHHHHCCCC | 14.04 | 24275569 | |
231 | Phosphorylation | FSHMLGATNPTQKTK HHHHHCCCCCCHHHH | 39.67 | 24275569 | |
290 | N-linked_Glycosylation | RIFSFEINVSVAIIT EEEECEEEEEEEEEE | 16.89 | UniProtKB CARBOHYD | |
313 (in isoform 2) | Phosphorylation | - | 32.30 | 24719451 | |
317 | Phosphorylation | NDNSRDMTEVISSLE CCCCCCHHHHHHHHH | 31.24 | 25072903 | |
321 | Phosphorylation | RDMTEVISSLENANY CCHHHHHHHHHHCCC | 33.76 | 25072903 | |
322 | Phosphorylation | DMTEVISSLENANYK CHHHHHHHHHHCCCC | 28.69 | 25072903 | |
328 | Phosphorylation | SSLENANYKDHENGT HHHHHCCCCCCCCCC | 18.51 | 25072903 | |
333 | N-linked_Glycosylation | ANYKDHENGTGTNTY CCCCCCCCCCCCCHH | 50.32 | 17027507 | |
361 | Phosphorylation | MRLLGMETMAWQEIR HHHHCCHHHHHHHHH | 11.87 | 24719451 | |
442 | Phosphorylation | HAFILQDTKALHQVF EEEEECCHHHHHHHH | 12.78 | 23403867 | |
456 | Phosphorylation | FEHMLDVSKLTDTIC HHHHHCHHHHHHCCC | 22.93 | 26714015 | |
467 | N-linked_Glycosylation | DTICGVGNMSANASD HCCCCCCCCCCCCCC | 20.87 | 16335952 | |
471 | N-linked_Glycosylation | GVGNMSANASDQERT CCCCCCCCCCCCCCC | 32.44 | 16335952 | |
516 | Phosphorylation | FRDGNDHSLWRVNVG EECCCCCEEEEEECC | 32.27 | 24719451 | |
527 | Phosphorylation | VNVGDPKSQWGKEFL EECCCCHHHCCHHHH | 36.23 | 24719451 | |
612 | Phosphorylation | NELLNKQSVPAHFVA HHHHCCCCCCEEEEE | 31.51 | - | |
621 | N-linked_Glycosylation | PAHFVALNGSKLNIN CEEEEEECCCEEEEE | 42.85 | 17623646 | |
621 | N-linked_Glycosylation | PAHFVALNGSKLNIN CEEEEEECCCEEEEE | 42.85 | 16335952 | |
651 | N-linked_Glycosylation | QEKTMFPNLTDVREV CCCCCCCCCCCHHHH | 44.29 | 16335952 | |
651 | N-linked_Glycosylation | QEKTMFPNLTDVREV CCCCCCCCCCCHHHH | 44.29 | 18638581 | |
660 | Phosphorylation | TDVREVVTDQFLCSG CCHHHHHHHHHCCCC | 29.29 | - | |
666 | Phosphorylation | VTDQFLCSGTQEDES HHHHHCCCCCCCCCC | 47.20 | - | |
668 | Phosphorylation | DQFLCSGTQEDESPC HHHCCCCCCCCCCCC | 16.70 | - | |
673 | Phosphorylation | SGTQEDESPCKGESG CCCCCCCCCCCCCCC | 48.17 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CO2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CO2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CO2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
217000 | Complement component 2 deficiency (C2D) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-112 AND ASN-333, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-112; ASN-333; ASN-467;ASN-471; ASN-621 AND ASN-651, AND MASS SPECTROMETRY. |